U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07703670) titled 'MicroRNAs as Biomarkers in First Episode Schizophrenia' on June 04.
Brief Summary: This study investigates whether tiny molecules called microRNAs (miRNAs), found in special brain-derived "packages" (neural-derived extracellular vesicles, or NDEs) that travel from the brain into the blood, can serve as helpful indicators (biomarkers) for schizophrenia. Currently, doctors diagnose schizophrenia and monitor treatment primarily through clinical interviews, which can be slow and imprecise. This study will work with 80 individuals recently diagnosed with first-episode schizophrenia who are beginning treatment with either aripiprazole or ...